A 2020 study in JAMA concluded that the pharma and health product industry spent $4.7 billion on campaign contributions and lobbying from 1999 to 2018. The paper concluded that such funding could stymie “government efforts to lower drug costs and other legislative and regulatory initiatives.”
https://www.statnews.com/feature/prescription-politics/prescription-politics/
Pharma Contributions and Lobbying donations:
Johnson & Johnson:
2020 Contributions: $2,138,687 Lobbying: $5,570,000
Contributions (since 1990): $13,922,661 Lobbying (since 1998): $126,811,000
https://www.opensecrets.org/orgs/johnson-johnson/summary?id=D000000386
Pfizer:
2020 Contributions: $4,052,368 Lobbying: $10,870,000
Contributions (since 1990): $30,954,692 Lobbying (since 1998): $223,187,918
https://www.opensecrets.org/orgs/pfizer-inc/summary?id=D000000138
AstraZeneca:
2020 Contributions: $1,029,039 Lobbying: $3,470,000
Contributions (since 1990): $10,138,358 Lobbying (since 1998): $67,936,213
https://www.opensecrets.org/orgs/astrazeneca-plc/summary?id=D000043112
Moderna:
2020 Lobbying: $280,000 (7x higher than 2019)
2021 Lobbying: $290,000
https://www.opensecrets.org/federal-lobbying/clients/summary?cycle=2021&id=D000073555
[link] [comments]
CURRENT BURN: 300,738,863
NEXT ACTIVATION: 400,000,000
VAULT ACCESS
Comments
Post a Comment